Press "Enter" to skip to content

Pediatric Vaccines Market Trends 2019 – Competitive Analysis by Demand Status, Valuable Insights of Business, Product Scope, Driving Factors Forecast to 2024


The “Pediatric Vaccines Market” report 2019 provides information for market players, stakeholders, investors, and business strategists to achieve a leading position the market. It maintains the record of Unusual growth strategies adopted by various companies are creating new standards for competition in the global Pediatric Vaccines market. Businesses around the world are aiming at increasing their profit margin and establishing a stronghold in the global market. The impact of prevailing regulatory scenario on both regional and worldwide Pediatric Vaccines market is provided in detail in the report.

Get a Sample Copy of the Report –  

Pediatric Vaccines Market Covers Key Players:

  • GlaxoSmithKline PLC
  • Indian Immunologicals Limited
  • AstraZeneca
  • Merck & Co. Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Seqirus (CSL Limited)

    Market Overview:

  • The global pediatric vaccine market is expected to register 11.7% CAGR during the forecast period 2019-2024. The growth of the pediatric vaccines market is attributed due to the rising burden of chronic disease with the importance and awareness of immunization, technological advancements in vaccines, an increase in the government and non-government funding in R&D.
  • As immunization plays a significant role in modern medicine, there are several international programs for children, which may vary based on the disease. However, these programs are primarily driving the demand for the pediatric vaccines market.
  • There are several chronic diseases among children, which make them further susceptible to severe manifestations and complications with chronic diseases, For example, diseases, such as allergic, cardiorespiratory, hematologic, metabolic, and renal disorders, among others, lead to an increased risk of developing influenza, varicella, and pneumococcal infection. The parental understanding regarding these complications and immunization benefits is also required to raise awareness regarding pediatric vaccines. The television, by far, is the most common source of information, followed by health professionals, newspapers, and magazines. The uptake of pediatric vaccination has improved through community-based vaccination program, which communicates the benefits and effectiveness of vaccines, hence promoting the growth of the pediatric vaccines market.
  • Furthermore, government initiatives, like Vaccines for Children Program, provides vaccines to children who lack health insurance or cannot afford the cost of vaccination, which is funded by the Centers for Medicare and Medicaid Services (CMS) to the Centers for Disease Control (CDC), and approved by the Office of Management and Budget.

    Report Highlights:

    • The report provides a detailed analysis on current and future market trends to identify the investment opportunities
    • Market forecasts till 2024, using estimated market values as the base numbers
    • Key market trends across the business segments, Regions and Countries
    • Key developments and strategies observed in the market
    • Market Dynamics such as Drivers, Restraints, Opportunities and other trends
    • In-depth company profiles of key players and upcoming prominent players
    • Growth prospects among the emerging nations through 2024
    • Pediatric Vaccines Market opportunities and recommendations for new investments

    For More Information or Query or Customization Before Buying, Visit at

    Scope of the Report:

  • As per the , pediatric vaccines are vaccines that stimulate the body’s immune response, in order to prevent a specific disease in children.

    Key Market Trends:

    The Conjugate Vaccine Segment, under Technology, is Expected to Grow at the Fastest Rate, during the Forecast Period

    The conjugate vaccine segment held a maximum share in 2018, and is likely to witness a rapid growth during the forecast period, due to the increasing prevalence of pneumococcal and meningococcal infections, and rise in the awareness regarding the prevention of infection, by government initiatives.

    The North American Region Holds the Largest Market Share of the Pediatric Vaccines Market and is Projected to Follow the Same Trend over the Forecast Period

    North America is expected to be the primary region for the pediatric vaccines market, over the forecast period. The scheduled children immunization programs under the Centers for Disease Control and Prevention (CDC), high funding, wide commercial availability of vaccines, and the awareness in society regarding vaccines contribute to the sustained growth in the United States. In Canada, the vaccination schedule for infants and children are regularly updated by the Government of Canada, in collaboration with the Canadian Nursing Coalition for Immunization (CNCI) and the Canadian Immunization Committee (CIC). The well-structured healthcare services boost the growth of the pediatric vaccines market in North America.

    Purchase this Report (Price 4250 USD for single user license) –

    Detailed TOC of Pediatric Vaccines Market Report 2019-2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Burden of Chronic Diseases with the Importance and Awareness of Immunization
    4.2.2 Technological Advancements in Vaccines
    4.2.3 Increase in the Government and Non-government Funding in R&D
    4.3 Market Restraints
    4.3.1 Cost of Immunization
    4.3.2 Low Medical Coverage and Healthcare Services in Low- and Middle-income Countries
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 By Vaccine Type
    5.1.1 Monovalent
    5.1.2 Multivalent
    5.2 By Technology
    5.2.1 Live Attenuated
    5.2.2 Inactivated
    5.2.3 Toxoid
    5.2.4 Conjugate
    5.2.5 Other Technologies
    5.3 By Application
    5.3.1 Infectious Disease
    5.3.2 Cancer
    5.3.3 Allergy
    5.3.4 Other Applications
    5.4 Geography
    5.4.1 North America US Canada Mexico
    5.4.2 Europe Germany UK France Italy Spain Rest of Europe
    5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.4.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.4.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 GlaxoSmithKline PLC
    6.1.2 Indian Immunologicals Limited
    6.1.3 AstraZeneca
    6.1.4 Merck & Co. Inc.
    6.1.5 Mitsubishi Tanabe Pharma Corporation
    6.1.6 Novartis AG
    6.1.7 Pfizer Inc.
    6.1.8 Sanofi SA
    6.1.9 Seqirus (CSL Limited)



    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    White Oil Market Size and Share 2019 | Global Industry Analysis By Trends, Future Demands, Growth Factors, Emerging Technologies, Prominent Players and Forecast Till 2026

    Invert Sugar Market 2019 Research by Business Opportunities, Top Manufacture, Industry Growth, Industry Share Report, Size, Regional Analysis and Global Forecast to 2023 | Industry Research Biz

    Global Mini C-arm Market Growth Rate 2019 – Business Strategy, Development Plans, and Key Technologies of Key Manufacturers Forecast to 2024

    Wireless Presenters Market 2019 Overview, Cost Structure Analysis, Growth Opportunities and Forecast to 2025

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *